Phosphoproteomic analysis of neoadjuvant breast cancer suggests that increased sensitivity to paclitaxel is driven by CDK4 and filamin ASilvana Mourón, Miguel Quintela-Fandiño, Isabel Calvo et al.|Nature Communications|2022Cited by 14
p27Kip1 V109G as a biomarker for CDK4/6 inhibitors indication in hormone receptor–positive breast cancerSilvana Mourón, Miguel Quintela-Fandiño, María J. Bueno et al.|JNCI Cancer Spectrum|2023Cited by 2